Search research articles
Contact Us
Filters
Showing results (71-80 of 102) with videos related to
Page
of 11
Sort By:
Diabetes Care
|
January 5, 2024
Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
François Roubille, Nadia Bouabdallaoui, Simon Kouz, et al.
Panminerva Medica
|
May 13, 2022
Impact of dual antiplatelet therapy duration on clinical outcome after coronary bifurcation stenting: results from the EuroBifurcation Club registry
Plinio Cirillo, Luigi DI Serafino, Habib Gamra, et al.
Lancet (London, England)
|
September 1, 2021
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
Philip Joseph, Gholamreza Roshandel, Peggy Gao, et al.
Atherosclerosis Plus
|
November 13, 2024
A collaborative effort across Africa to investigate risk factors and outcomes of premature acute coronary syndrome: Protocol for the EAS Lipid Registry of Africa (LIPRA)
Ashraf Reda, Alexander R M Lyons, Alberto Zambon, et al.
European Heart Journal
|
August 29, 2025
2025 ESC/EACTS Guidelines for the management of valvular heart disease
Fabien Praz, Michael A Borger, Jonas Lanz, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
August 29, 2025
2025 ESC/EACTS Guidelines for the management of valvular heart disease
Fabien Praz, Michael A Borger, Jonas Lanz, et al.
European Heart Journal
|
August 30, 2020
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
Nadia Bouabdallaoui, Jean-Claude Tardif, David D Waters, et al.
Giornale Italiano Di Cardiologia (2006)
|
November 25, 2025
[2025 ESC/EACTS Guidelines for the management of valvular heart disease]
Fabien Praz, Michael A Borger, Jonas Lanz, et al.
The New England Journal of Medicine
|
November 17, 2019
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif, Simon Kouz, David D Waters, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
May 15, 2020
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
Michelle Samuel, Jean-Claude Tardif, Paul Khairy, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 102) with videos related to
Sort By:
Page
of 11
Diabetes Care
|
January 5, 2024
Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
François Roubille, Nadia Bouabdallaoui, Simon Kouz, et al.
Panminerva Medica
|
May 13, 2022
Impact of dual antiplatelet therapy duration on clinical outcome after coronary bifurcation stenting: results from the EuroBifurcation Club registry
Plinio Cirillo, Luigi DI Serafino, Habib Gamra, et al.
Lancet (London, England)
|
September 1, 2021
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
Philip Joseph, Gholamreza Roshandel, Peggy Gao, et al.
Atherosclerosis Plus
|
November 13, 2024
A collaborative effort across Africa to investigate risk factors and outcomes of premature acute coronary syndrome: Protocol for the EAS Lipid Registry of Africa (LIPRA)
Ashraf Reda, Alexander R M Lyons, Alberto Zambon, et al.
European Heart Journal
|
August 29, 2025
2025 ESC/EACTS Guidelines for the management of valvular heart disease
Fabien Praz, Michael A Borger, Jonas Lanz, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
August 29, 2025
2025 ESC/EACTS Guidelines for the management of valvular heart disease
Fabien Praz, Michael A Borger, Jonas Lanz, et al.
European Heart Journal
|
August 30, 2020
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
Nadia Bouabdallaoui, Jean-Claude Tardif, David D Waters, et al.
Giornale Italiano Di Cardiologia (2006)
|
November 25, 2025
[2025 ESC/EACTS Guidelines for the management of valvular heart disease]
Fabien Praz, Michael A Borger, Jonas Lanz, et al.
The New England Journal of Medicine
|
November 17, 2019
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif, Simon Kouz, David D Waters, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
May 15, 2020
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
Michelle Samuel, Jean-Claude Tardif, Paul Khairy, et al.
Page
of 11